Lupin Ltd. is in Pharmaceuticals & Drugs. It was incorporated in year 1983. The current market capitalisation stands Rs 33013 Cr. The company is listed on the Bombay Stock Exchange (BSE) with the BSE code as 500257. and also listed on National Stock Exchange (NSE) with NSE code as LUPIN.
Lupin Limited, a pharmaceutical company, develops, produces, and markets a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) worldwide. The offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthama, pediatrics, central nervous system, gastro-intestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, anti-TB, and cephalosporin. The also develops drug delivery systems; and offers biosimilars for various therapies, such as oncology, inflammation, ophthalmology, rheumatoid arthritis, and osteoporosis. In addition, it is involved in the novel drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders. The was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited Lupin Limited was founded in 1968 and is based in Mumbai, India.
Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing.
Past performance is not indicative of future returns. Please consider your specific investment requirements, risk tolerance, investment goal, time frame, risk and reward balance and the cost associated with the investment before choosing a fund, or designing a portfolio that suits your needs.